"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This trial is a 12 week, randomized, double-blind, placebo controlled, multicenter, 5-arm
parallel group study of safety and efficacy of JZP-110 in the treatment of excessive
sleepiness in adult subjects with OSA.